Selank
Molecular Identifiers
Overview
Anxiolytic peptide derived from tuftsin with a Pro-Gly-Pro addition. Reduces anxiety without sedation. Immunomodulatory properties.
TKPRPGP Thr-Lys-Pro-Arg-Pro-Gly-Pro Half-life
~3-5 minutes
Administration Route
Intranasal or subcutaneous
Category
Cognitive & Neuroprotective
Mechanism of Action
- GABAergic system modulation
- Anxiolytic effect without sedation
- Immune modulation (IL-6, interferons)
- Stabilization of endogenous enkephalins
- Neuroprotective effect
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 250-500 mcg per injection |
| Frequency | 1-2 times daily |
| Timing | Morning and/or afternoon |
| Duration | 4-8 weeks |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Mild fatigue
- Nasal irritation (intranasal)
- Headache (rare)
Presentations & Preparation
Vials of Selank found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 2 ml per vial
- Slowly inject the diluent against the vial wall
- Gently swirl until fully dissolved
- Also available in nasal formulation
Storage
- Lyophilized: Refrigerated 2-8°C
- Reconstituted: Refrigerated 2-8°C (up to 30 days)
- Protect from direct light
- Do not freeze after reconstitution
Scientific Studies
Published studies on Selank.
Related Peptides
Adamax
100-500 mcg via intranasal or subcutaneous · 1-2 times daily
Cerebrolysin
5-30 ml per injection · Once daily
Cortagen
5-10 mg per day via subcutaneous injection · Once daily
Dihexa
10-20 mg per subcutaneous injection or oral (research) · Once daily
DSIP
100-300 mcg per subcutaneous injection · Once daily
Epithalon
5-10 mg per injection · Once daily or every other day